Very low protein diet reduces indoxyl sulfate levels in chronic kidney disease

Blood Purif. 2013;35(1-3):196-201. doi: 10.1159/000346628. Epub 2013 Mar 13.

Abstract

Background and objectives: High levels of indoxyl sulfate (IS) are associated with chronic kidney disease (CKD) progression and increased mortality in CKD patients. The aim of this pilot study was to assess whether a very low protein diet (VLPD; 0.3 g/kg bw/day), with a consequent low phosphorus intake, would reduce IS serum levels compared to a low protein diet (LPD; 0.6 g/kg bw/day) in CKD patients not yet on dialysis.

Material and methods: This is a post hoc analysis of a preceding cross-over study aimed to analyze FGF23 during VLPD. Here we performed a prospective randomized controlled crossover study in which 32 patients were randomized to receive either a VLPD (0.3 g/kg bw/day) supplemented with ketoanalogues during the first week and an LPD during the second week (group A, n = 16), or an LPD during the first week and a VLPD during the second week (group B, n = 16 patients). IS serum levels were measured at baseline and at the end of each study period. We compared them to 24 hemodialysis patients (HD) and 14 healthy subjects (control).

Results: IS serum concentration was significantly higher in the HD (43.4 ± 12.3 µM) and CKD (11.1 ± 6.6 µM) groups compared to the control group (2.9 ± 1.1 µM; p < 0.001). IS levels also correlated with creatinine values in CKD patients (R(2) = 0.42; p < 0.0001). After only 1 week of a VLPD, even preceded by an LPD, CKD patients showed a significant reduction of IS serum levels (37%).

Conclusions: VLPD supplemented with ketoanalogues reduced IS serum levels in CKD patients not yet on dialysis.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Amino Acids / administration & dosage*
  • Case-Control Studies
  • Creatinine / blood
  • Cross-Over Studies
  • Diet, Protein-Restricted*
  • Disease Progression
  • Female
  • Fibroblast Growth Factor-23
  • Humans
  • Indican / blood*
  • Keto Acids / administration & dosage*
  • Male
  • Middle Aged
  • Pilot Projects
  • Prospective Studies
  • Renal Dialysis
  • Renal Insufficiency, Chronic / blood
  • Renal Insufficiency, Chronic / diet therapy*
  • Treatment Outcome

Substances

  • Amino Acids
  • FGF23 protein, human
  • Keto Acids
  • Fibroblast Growth Factor-23
  • Creatinine
  • Indican